Health Care & Life Sciences » Biotechnology | LegoChem Biosciences Inc.

LegoChem Biosciences Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
840
870
1,788
16,655
22,057
Cost of Goods Sold (COGS) incl. D&A
25
-
1,086
13,973
16,820
Gross Income
814
-
703
2,682
5,236
SG&A Expense
7,074
8,983
8,752
12,855
15,078
EBIT
6,260
8,457
8,049
10,173
9,842
Unusual Expense
127
68
49
4,627
2,864
Non Operating Income/Expense
1
21
38
106
96
Interest Expense
52
209
878
1,073
1,353
Pretax Income
5,835
8,197
8,404
15,361
13,498
Income Tax
-
489
167
636
564
Consolidated Net Income
5,835
8,686
8,237
14,725
12,934
Net Income
5,835
8,686
8,237
14,725
12,934
Net Income After Extraordinaries
5,835
8,686
8,237
14,725
12,934
Net Income Available to Common
5,835
8,686
8,237
14,725
12,934
EPS (Basic)
879.00
1,201.00
1,067.00
1,561.00
1,300.00
Basic Shares Outstanding
7
7
8
9
10
EPS (Diluted)
878.89
1,201.43
1,067.45
1,561.22
1,299.71
Diluted Shares Outstanding
7
7
8
9
10
EBITDA
6,234
8,113
7,654
8,022
7,203
Other Operating Expense
-
-
-
-
-
Non-Operating Interest Income
349
380
436
406
465

About LegoChem Biosciences

View Profile
Address
8-26 Munpyeongseo-ro
Daejeon DE 34302
Korea, Republic Of
Employees -
Website http://www.legochembio.com
Updated 09/14/2018
LegoChem Biosciences, Inc. engages in the development and manufacturing of pharmaceuticals. Its main therapeutic areas include antibiotics, anti-coagulants, oncology, antibody-drug conjugate and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.